CHIMERIX INC. - COMMON STOCK

Chimerix Reports First Quarter 2024 Financial Results and Provides Operational Update

01 5月 2024 07:00:00 条件 Nasdaq GlobeNewswire

Chimerix to Report First Quarter 2024 Financial Results and Provide an Operational Update on May 1, 2024

24 4月 2024 07:00:00 条件 Nasdaq GlobeNewswire

Chimerix Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

16 4月 2024 16:05:00 条件 Nasdaq GlobeNewswire

Chimerix Appoints Marc D. Kozin to Board of Directors

21 3月 2024 07:00:00 条件 Nasdaq GlobeNewswire

Chimerix Reports Fourth Quarter and Year End 2023 Financial Results and Provides Operational Update

29 2月 2024 07:00:00 条件 Nasdaq GlobeNewswire

Chimerix to Present at TD Cowen 44th Annual Health Care Conference

27 2月 2024 07:00:00 条件 Nasdaq GlobeNewswire

Chimerix to Report Fourth Quarter and Year End 2023 Financial Results and Provide an Operational Update on February 29, 2024

22 2月 2024 07:00:00 条件 Nasdaq GlobeNewswire

Chimerix Appoints Lisa Decker to Board of Directors

29 12月 2023 07:00:00 条件 Nasdaq GlobeNewswire

Chimerix Promotes Michelle LaSpaluto to Chief Financial Officer

04 12月 2023 07:00:00 条件 Nasdaq GlobeNewswire

Chimerix Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

24 11月 2023 07:00:00 条件 Nasdaq GlobeNewswire

Chimerix Strengthens Executive Leadership Team with Appointment of Thomas Riga as Chief Operating and Commercial Officer

16 11月 2023 07:00:00 条件 Nasdaq GlobeNewswire

NetDania - New 12 months Low: CHIMERIX INC. - COMMON STOCK

10 11月 2023 10:32:10 条件 NetDania Notify

Chimerix Reports Third Quarter 2023 Financial Results and Provides Operational Update

02 11月 2023 07:00:00 条件 Nasdaq GlobeNewswire

NetDania - New 12 months Low: CHIMERIX INC. - COMMON STOCK

27 10月 2023 10:02:41 条件 NetDania Notify

Chimerix to Report Third Quarter 2023 Financial Results and Provide an Operational Update on November 2, 2023

26 10月 2023 07:00:00 条件 Nasdaq GlobeNewswire

NetDania - New 12 months Low: CHIMERIX INC. - COMMON STOCK

18 8月 2023 09:48:49 条件 NetDania Notify

Chimerix Announces Data Highlighting Clinical Efficacy and Molecular Mechanisms of Response to ONC201 Treatment of H3 K27M-Mutant Diffuse Midline Gliomas Published in "Cancer Discovery"

16 8月 2023 10:05:00 条件 Nasdaq GlobeNewswire

NetDania - New 12 months Low: CHIMERIX INC. - COMMON STOCK

16 8月 2023 09:58:09 条件 NetDania Notify

NetDania - New 12 months Low: CHIMERIX INC. - COMMON STOCK

14 8月 2023 09:52:38 条件 NetDania Notify

NetDania - New 12 months Low: CHIMERIX INC. - COMMON STOCK

11 8月 2023 11:07:38 条件 NetDania Notify